Please assess the completion status of the following clinical trial:

Trial Title: Study of Placebo or Bosentan to Treat Patients With Single Ventricle Physiology.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* TCPC operated~* Age \> 15 years old~* Clinical stability \> 3 months, evaluated by investigator from clinical record~* For women: Negative s-hCG and use of contraception~Exclusion Criteria:~* Severe heart failure (NYHA-class IV)~* Oxygen saturation \< 85 % at rest~* Pre-existing liver condition (transaminases 2x \> reference)~* Renal failure (creatinin \> 150 mmol/l)~* Obstruction of TCPC circulation~* History of work induced severe arrhythmia~* Systolic blood pressure below 80% of reference (BT \< 88 mmHg)~* Use of any of following drugs: Fluconazol, Ketoconazole, CiclosporinA, Lopinavir, Ritonavir, Rifampicin, Carbamazepin and Phenytoin~* Significant extra-cardiac condition e.g. neurological impairment

- Gender: ALL
- Minimum Age: 15 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Bosentan (Type: ACTIVE_COMPARATOR): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).